Stock listing
NASDAQ:PRVL Prevail Therapeutics Inc Stock
Follow Prevail Therapeutics Inc into a list and get an email when it puts out news.
Last close · NASDAQ:PRVL
$23.00 USD
Close on Jan 26, 2021 · No longer trades
- Lowest – highest close
- $8.05 – $23.20 USDSince Jun 20, 2019 · lowest Aug 8, 2019 · highest Jan 8, 2021
Delisted NASDAQ:PRVL no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:PRVL
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Prevail Therapeutics Inc on 6ix
- Decks
- 3 decks · latest Aug 11, 2020
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q2 2020 Earnings Presentation | Earnings | 21 slides | Aug 11, 2020 |
| Investor Presentation (March 2020) | Investor deck | 30 slides | Mar 3, 2020 |
| Investor Presentation (January 2020) | Investor deck | 30 slides | Jan 13, 2020 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Carl Gordon Other companies: ADARx Pharmaceuticals, Inc. (Co-head Global Private Equity at OrbiMed Advisors · Since at least Sep 24, 2026); Electra Therapeutics, Inc. (Director · Since at least Sep 18, 2026); BlossomHill Therapeutics, Inc. (Board Member · Since at least Aug 6, 2026); Scribe Therapeutics Inc. (Director · Since at least Jul 23, 2026); Compass Therapeutics, Inc. (Founding Member, Managing Partner, and Co-Head of Global Private Equity, OrbiMed Advisors LLC · Since at least Jun 17, 2020); Keros Therapeutics, Inc. (Director · Since at least Apr 7, 2020); MBX Biosciences, Inc. (Director · Sep 12, 2024 – Feb 14, 2025 · Past); ArriVent BioPharma, Inc. (Director · Jan 25, 2024 – Jan 30, 2024 · Past); Theseus Pharmaceuticals Inc (Director · Oct 6, 2021 – Feb 14, 2024 · Past); Disc Medicine, Inc. (Director · Feb 5, 2021 – Oct 4, 2021 · Past); Terns Pharmaceuticals, Inc. (Director · Feb 4, 2021 – Jul 15, 2024 · Past); Kinnate Biopharma Inc (Director · Dec 2, 2020 – Apr 3, 2024 · Past); Adicet Bio, Inc. (Director · Sep 15, 2020 – Aug 21, 2024 · Past); ORIC Pharmaceuticals, Inc. (Director · Apr 23, 2020 – Jun 16, 2021 · Past); SpringWorks Therapeutics Inc (Director · Sep 12, 2019 – Sep 12, 2019 · Past); Turning Point Therapeutics Inc (Director · Apr 16, 2019 – Jun 15, 2020 · Past); Alector, Inc. (Director · Feb 6, 2019 – May 10, 2019 · Past); Armo Biosciences Inc. (Director · Jan 25, 2018 – Jun 22, 2018 · Past); X4 Pharmaceuticals, Inc. (Director · Nov 15, 2017 – Jun 5, 2018 · Past); Cartesian Therapeutics, Inc. (Director · Jun 21, 2016 – Jun 27, 2016 · Past); Intellia Therapeutics, Inc. (Director · May 5, 2016 – May 18, 2017 · Past); Acceleron Pharma Inc (Director · Sep 18, 2013 – Sep 18, 2013 · Past); Pacira BioSciences, Inc. (Director · Feb 2, 2011 – Feb 8, 2011 · Past); Amarin Corporation plc (Director · Dec 30, 2010 – Sep 4, 2012 · Past); BioCryst Pharmaceuticals, Inc. (Director · May 17, 2006 – May 17, 2006 · Past) | Director · Jun 19, 2019 – Jan 22, 2021 · Past |
| Peter Thompson Other companies: Aspen Neuroscience, Inc. (General Partner · Since at least Nov 2, 2026); Sionna Therapeutics, Inc. (Director · Since at least Feb 6, 2025); Edgewise Therapeutics, Inc. (Chairman and Co-Founder · Since at least Mar 25, 2021); ARS Pharmaceuticals, Inc. (Director · Since at least Dec 3, 2020); Corvus Pharmaceuticals, Inc. (CO-FOUNDER · Since at least Mar 22, 2016); Janux Therapeutics, Inc. (Director · Jun 10, 2021 – Jun 14, 2022 · Past); Decibel Therapeutics Inc (Director · Feb 11, 2021 – Jun 17, 2022 · Past); PMV Pharmaceuticals, Inc. (Director · Sep 24, 2020 – Jun 2, 2021 · Past); Synthorx Inc (Director · Dec 6, 2018 – Jan 23, 2020 · Past); Principia Biopharma Inc (Director · Sep 13, 2018 – Sep 13, 2018 · Past); Alpine Immune Sciences Inc (Director · Jul 24, 2017 – May 18, 2024 · Past); Adaptimmune Therapeutics PLC (Director · Jan 1, 2016 – Jun 4, 2018 · Past); Sierra Oncology Inc (Director · Jul 15, 2015 – Jul 21, 2015 · Past); Anthera Pharmaceuticals Inc (Director · Feb 1, 2011 – May 8, 2012 · Past); Trubion Pharmaceuticals Inc (President and CEO, Director · Oct 17, 2006 – Aug 27, 2009 · Past) | Director · Jun 19, 2019 – Jan 22, 2021 · Past |
| Tim M Adams Other companies: Shutterstock, Inc. (Director · Since at least Sep 8, 2026); Rapid7, Inc. (Chief Financial Officer · Since at least Jan 3, 2022); Model N Inc (Director · Dec 23, 2016 – Jun 27, 2024 · Past); Demandware Inc (See Remarks · Jun 2, 2014 – Jul 11, 2016 · Past); Macy's Inc (Chief Private Brand Officer · Apr 9, 2010 – Dec 29, 2014 · Past); athenahealth Inc (CFO & SVP · Jan 11, 2010 – Apr 1, 2014 · Past); Orthofix Medical Inc. (Chief Financial Officer · Nov 19, 2007 – Apr 30, 2008 · Past); Adeza Biomedical Corp (Director · Mar 19, 2007 – Mar 19, 2007 · Past); Cytyc Corp (Chief Financial Officer · Jan 24, 2006 – Oct 22, 2007 · Past) | Director · Jun 19, 2019 – Jan 22, 2021 · Past |
| François Nader Other companies: Tectonic Therapeutic, Inc. (Chair, Board of Directors · Since at least Feb 23, 2026); Moderna, Inc. (Director · Since at least Dec 10, 2019); Tourmaline Bio Inc. (Director · May 6, 2021 – Jun 13, 2023 · Past); Alexion Pharmaceuticals Inc (Director · Nov 15, 2017 – Jul 21, 2021 · Past); Baxalta Inc (Director · Jul 27, 2015 – Jun 3, 2016 · Past); Acceleron Pharma Inc (Director · Dec 11, 2014 – Nov 19, 2021 · Past); Trevena, Inc. (Director · Jan 30, 2014 – May 20, 2015 · Past); NPS Pharmaceuticals Inc (President, CEO and Director, Director · Apr 8, 2013 – Feb 21, 2015 · Past) | Director · Jun 19, 2019 – Jan 22, 2021 · Past |
| Ran Nussbaum Other companies: LB Pharmaceuticals Inc (Director · Since at least Sep 10, 2025); Keros Therapeutics, Inc. (Director · Since at least Apr 7, 2020); UroGen Pharma Ltd. (Director · Jan 1, 2019 – Oct 21, 2022 · Past); ArQule Inc (Director · Nov 8, 2017 – Jan 16, 2020 · Past); VBI Vaccines Inc. (Director · Oct 30, 2017 – Oct 30, 2017 · Past); Kite Pharma Inc (Director · Jun 19, 2014 – Oct 3, 2017 · Past) | Director · Jun 19, 2019 – Jan 22, 2021 · Past |
| Brett Kaplan Other companies: Climb Bio, Inc. (Chief Operating Officer · Aug 26, 2024 – Jan 13, 2025 · Past); Compass Therapeutics, Inc. (Director · Sep 10, 2020 – Feb 18, 2022 · Past) | Chief Financial Officer · Jun 19, 2019 – Jan 22, 2021 · Past |
| Jeffrey Sevigny Other companies: Rapport Therapeutics, Inc. (Chief Medical Officer · Since at least Mar 3, 2025); Acumen Pharmaceuticals, Inc. (Director · Jun 30, 2021 – Jun 15, 2022 · Past) | Chief Medical Officer · Jun 19, 2019 – Jan 22, 2021 · Past |
| William H. Carson Other companies: Annexon, Inc. (BOARD MEMBER · Since at least Feb 5, 2021); Decibel Therapeutics Inc (Director · Jun 2, 2021 – Sep 25, 2023 · Past) | Director · Sep 9, 2020 – Jan 22, 2021 · Past |
| Asa Abeliovich | President & CEO, Director · Dec 30, 2020 – Jan 22, 2021 · Past |
| Emily Minkow | Chief Business Officer · Jun 19, 2019 – Jan 22, 2021 · Past |
All 14 people
| Person | Seat |
|---|---|
| Franz Hefti | Chief Development Officer · Jun 19, 2019 – Jan 22, 2021 · Past |
| Kira M Schwartz | General Counsel · Jun 1, 2020 – Jan 22, 2021 · Past |
| Morgan Sheng | Director · Nov 15, 2019 – Jan 22, 2021 · Past |
| Yong Dai | Chief Technology Officer · Jun 19, 2019 – Jan 22, 2021 · Past |
Log in to ask 6ix AI your own questions about Prevail Therapeutics Inc.